🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust market exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers market the drug there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Some experts stated the demand for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the platform has removed problematic content and prohibited associated keywords and query recommendations. The company stated it was committed to maintaining the platform safe and investing in enhancing compliance measures.

Online Trading Operations

Investigations also discovered groups with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, filled with images of weight loss, glowing reviews and detailed instructions for preparing or administering at home.

Within minutes of joining one group, a vendor posted WhatsApp details, where most purchases occur. The seller sent an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Item Information and Pricing

Inside these groups, messages show black plastic parcels with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When asked how much time a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for Telegram said it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Even if the research behind retatrutide is sound, these online products may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject users to possibly significant health risks”.